Life sciences news
-
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
Monday August 30th 2021
Read more
-
argenx announces validation of European marketing authorization application for Efgartigimod in generalized myasthenia gravis
Wednesday August 25th 2021
Read more
-
Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies
Wednesday August 18th 2021
Read more
-
Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science
Tuesday August 17th 2021
Read more
-
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Wednesday July 28th 2021
Read more
-
Allegro inaugrates new lab at Bluechem
Tuesday July 27th 2021
Read more
-
eTheRNA immunotherapies appoints Mathieu Lane as Chief Financial Officer and President of eTheRNA Inc. located in the U.S.A
Tuesday July 27th 2021
Read more
-
Biocair opens new office in South Africa, a clinical research hub
Wednesday July 21st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Bone Therapeutics provides update on the progress of clinical studies
Monday July 19th 2021
Read more
-
Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
Thursday July 15th 2021
Read more
-
ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments
Thursday July 15th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
